Related references
Note: Only part of the references are listed.Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp)
Hang Zhang et al.
MEDICINAL RESEARCH REVIEWS (2021)
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Karthik Dhatchinamoorthy et al.
FRONTIERS IN IMMUNOLOGY (2021)
Phytochemicals reverse P-glycoprotein mediated multidrug resistance via signal transduction pathways
M. Ganesan et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring
Elias Jabbour et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Karol Bukowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy
Annelisa M. Cornel et al.
CANCERS (2020)
Thimet Oligopeptidase Biochemical and Biological Significances: Past, Present, and Future Directions
Emer S. Ferro et al.
BIOMOLECULES (2020)
Prolonged inhibition of P-glycoprotein after exposure to chemotherapeutics increases cell mortality in multidrug resistant cultured cancer cells
Amila K. Nanayakkara et al.
PLOS ONE (2019)
Thimet Oligopeptidase (EC 3.4.24.15) Key Functions Suggested by Knockout Mice Phenotype Characterization
Nilton B. dos Santos et al.
BIOMOLECULES (2019)
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP
Michele Baccarani et al.
BLOOD ADVANCES (2019)
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Deepali Waghray et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database
Neil D. Rawlings et al.
NUCLEIC ACIDS RESEARCH (2018)
The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer
Andre Steven et al.
BREAST CARE (2018)
Total HLA Class I Antigen Loss with the Downregulation of Antigen-Processing Machinery Components in Two Newly Established Sarcomatoid Hepatocellular Carcinoma Cell Lines
Wei-Yi Lei et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Antigen processing and immune regulation in the response to tumours
Emma Reeves et al.
IMMUNOLOGY (2017)
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer
Scott Gettinger et al.
CANCER DISCOVERY (2017)
Redox modulation of thimet oligopeptidase activity by hydrogen peroxide
Marcelo Y. Icimoto et al.
FEBS OPEN BIO (2017)
TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer
Agnes Ling et al.
ONCOIMMUNOLOGY (2017)
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Behzad Mansoori et al.
ADVANCED PHARMACEUTICAL BULLETIN (2017)
A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells
Vanessa Lopes-Rodrigues et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Toward a Better Understanding of the Complexity of Cancer Drug Resistance
Michael M. Gottesman et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Clinical Role of Human Leukocyte Antigen in Health and Disease
Y. M. Mosaad
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2015)
Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma
Prahlad V. Raninga et al.
ONCOTARGET (2015)
K562 cells display different vulnerability to H2O2 induced oxidative stress in differing cell cycle phases
Handan Akcakaya et al.
CELL BIOLOGY INTERNATIONAL (2015)
Expression Analysis of THOP1 in Background Liver, a Prognostic Predictive Factor in Hepatocellular Carcinoma, Extracted by Multiarray Analysis
Shuji Nomoto et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Expression of THOP1 and Its Relationship to Prognosis in Non-Small Cell Lung Cancer
Lei Qi et al.
PLOS ONE (2014)
Inhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?
Richard Callaghan et al.
DRUG METABOLISM AND DISPOSITION (2014)
Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?
Vivian M. Rumjanek et al.
BIOSCIENCE REPORTS (2013)
Shear stress is a positive regulator of thimet oligopeptidase (EC3.4.24.15) in vascular endothelial cells: consequences for MHC1 levels
Anthony F. Guinan et al.
CARDIOVASCULAR RESEARCH (2013)
MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
Patrizia Leone et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
P-glycoprotein Inhibition for Optimal Drug Delivery
Md. Lutful Amin
DRUG TARGET INSIGHTS (2013)
The LMP7-K Allele of the Immunoproteasome Exhibits Reduced Transcript Stability and Predicts High Risk of Colon Cancer
Barbara Fellerhoff et al.
CANCER RESEARCH (2011)
The P-glycoprotein multidrug transporter
Frances J. Sharom
ESSAYS IN BIOCHEMISTRY: ABC TRANSPORTERS (2011)
Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes
Jan H. Kessler et al.
NATURE IMMUNOLOGY (2011)
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma
Vito Racanelli et al.
BLOOD (2010)
Structure and function of major histocompatibility complex class I antigens
Xian C. Li et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2010)
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Stephen A. Bustin et al.
CLINICAL CHEMISTRY (2009)
In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray
S. Hoves et al.
LEUKEMIA (2009)
Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth
Thaysa Paschoalin et al.
MOLECULAR CANCER (2007)
Levels of soluble HLA-I and b2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy
M. Albitar et al.
LEUKEMIA (2007)
Total loss of MHC class I is an independent indicator of good prognosis in breast cancer
Z Madjd et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Mechanisms of immune evasion of human neuroblastoma
L Raffaghello et al.
CANCER LETTERS (2005)
Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the 'PrOxI' hypothesis
CY Teoh et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Contribution of β-2 microglobulin levels to the prognostic stratification of survival in patients with myelodysplastic syndrome (MDS)
S Gatto et al.
BLOOD (2003)
The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation
IA York et al.
IMMUNITY (2003)
Substrate specificity characterization of recombinant metallo oligo-peptidases thimet oligopeptidase and neurolysin
V Oliveira et al.
BIOCHEMISTRY (2001)
Multidrug resistance in tumour cells: characterisation of the multidrug resistant cell line K562-Lucena 1
VM Rumjanek et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2001)
Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin
K Delp et al.
BONE MARROW TRANSPLANTATION (2000)
A novel stable inhibitor of endopeptidases EC 3.4.24.15 and 3.4.24.16 potentiates bradykinin-induced hypotension
AI Smith et al.
HYPERTENSION (2000)
Share Paper
